AcquisitionThe announced acquisition by Alcon is seen as a positive outcome for both Lensar and Alcon, with Lensar experiencing strong adoption of its ALLY System in the cataract surgery market.
Financial PerformanceThe company reported Q4 revenue of $16.7M, which was 38% higher than the previous year and above market expectations.
Market PerformanceLENSAR's installed base for the ALLY system grew by 86%, suggesting strong demand and expansion potential.